Cargando…
New Pharmaceutical Treatment of Gastric MALT Lymphoma: Anti-angiogenesis Treatment using VEGF Receptor Antibodies and Celecoxib
In addition to eradication of Helicobacter pylori, chemotherapy with anticancer agents, and radiation therapy, the treatment with molecular target drugs including rituximab, a CD20 antagonist, is one of the promising new regimens. The mucosa-associated lymphoid tissue (MALT) lymphoma is histological...
Autores principales: | Nakamura, Masahiko, Takahashi, Tetsufumi, Matsui, Hidenori, Takahashi, Shinichi, Murayama, Somay Y, Suzuki, Hidekazu, Tsuchimoto, Kanji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260359/ https://www.ncbi.nlm.nih.gov/pubmed/23782142 http://dx.doi.org/10.2174/13816128113199990420 |
Ejemplares similares
-
Draft Genome Sequence of Helicobacter suis Strain SNTW101, Isolated from a Japanese Patient with Nodular Gastritis
por: Matsui, Hidenori, et al.
Publicado: (2016) -
Lansoprazole Novel Effector Sites Revealed by Autoradiography: Relation to Helicobacter pylori, Colon, Esophagus and Others
por: Nakamura, Masahiko, et al.
Publicado: (2007) -
Effect of Acid Suppressants on Non–Helicobacter pylori Helicobacters Within Parietal Cells
por: Nakamura, Masahiko, et al.
Publicado: (2022) -
Musashi-1 Post-Transcriptionally Enhances Phosphotyrosine-Binding Domain-Containing m-Numb Protein Expression in Regenerating Gastric Mucosa
por: Takahashi, Tetsufumi, et al.
Publicado: (2013) -
Investigating the effect of vandetanib and celecoxib combination on angiogenesis
por: Qadir, Abdul, et al.
Publicado: (2023)